$0.432
+0 (+0%)
At Close: Sep 30, 2024
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
04:01pm, Thursday, 29'th Feb 2024
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter and full year ended December 31, 2023, and provided an upd
Should You Sell Your Penny Stocks? 3 Tips for When to Sell
06:12am, Tuesday, 27'th Feb 2024
Investing in penny stocks offers a unique opportunity for investors looking to expand their portfolios with potentially high-reward options. Recognized for their affordability, these stocks allow indi
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastat
Why Is Akili (AKLI) Stock Up 110% Today?
01:51pm, Monday, 26'th Feb 2024
A little known penny stock is turning heads on Wall Street today as it surges to impressive heights. Digital health company Akili Interactive Labs (NASDAQ: AKLI ) stock is soaring after reporting a po
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submitted Akili's digital therapeutic SDT-001
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today provided several corporate updates, including that it plans to report fourth quarter and full year 2023 f
Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
11:17am, Monday, 15'th Jan 2024
Akili, Inc. (AKLI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a
Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know
01:32pm, Thursday, 21'st Dec 2023
Akili, Inc. (AKLI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Akili, Inc. (AKLI) Q3 2023 Earnings Call Transcript
08:03am, Sunday, 12'th Nov 2023
Akili, Inc. (NASDAQ:AKLI ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Caty Reid - Vice President Marketing & Communications Matt Franklin - President & Chief Ope
Akili to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9 at 4:30 p.m. ET
12:27pm, Thursday, 19'th Oct 2023
BOSTON--(BUSINESS WIRE)--Akili to Host Third Quarter Financial Results Conference Call on Thursday, November 9 at 4:30 p.m.
Employees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study Finds
08:00am, Thursday, 12'th Oct 2023
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), the leading digital medicine company behind EndeavorOTC™, today released results from a new study examining the ways in which ADHD impacts the U.
Akili Announces Leadership Transition
07:00am, Friday, 06'th Oct 2023
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that Eddie Martucci transitioned to the role of Board chair, and Matt Franklin has been appoint
Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD
08:00am, Thursday, 21'st Sep 2023
BOSTON--(BUSINESS WIRE)--Akili Releases EndeavorOTC on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD.
Akili Announces Business Transformation, Focusing on Non-prescription Model
08:00am, Wednesday, 13'th Sep 2023
BOSTON--(BUSINESS WIRE)--Akili plans transition to non-Rx business, increasing patient access to clinically-proven non-drug treatments and reducing reliance on intermediaries.
Akili, Inc. (AKLI) Q2 2023 Earnings Call Transcript
09:27am, Sunday, 13'th Aug 2023
Akili, Inc. (NASDAQ:AKLI ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Julie DiCarlo - Senior Vice President, Communications Eddie Martucci - Chief Executive Offic
Sign In
Buy AKLI